- Report
- January 2021
- 600 Pages
United States
From €2691EUR$2,800USD£2,308GBP
- Report
- April 2023
- 129 Pages
Global
€4806EUR$5,000USD£4,121GBP
- Report
- July 2020
- 1740 Pages
Global
From €4614EUR$4,800USD£3,956GBP
Novantrone (mitoxantrone) is a chemotherapy drug used to treat certain types of breast cancer. It is used to treat metastatic breast cancer that has spread to other parts of the body, as well as hormone-receptor-positive breast cancer that has spread to the lymph nodes. It is also used to treat advanced forms of breast cancer that have not responded to other treatments. Novantrone works by interfering with the growth of cancer cells, slowing their growth and spread.
Novantrone is typically administered intravenously, and is usually given in combination with other chemotherapy drugs. Common side effects of Novantrone include nausea, vomiting, hair loss, and fatigue. It can also cause damage to the heart, so it is important to monitor heart function during treatment.
Novantrone is manufactured by Sanofi-Aventis, and is available in the United States, Canada, and Europe. Other companies that produce similar drugs include Pfizer, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more